Back to Search

A Phase 1/1b/2 Study Evaluating the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Efficacy of AMG 193 Alone and in Combination With Docetaxel in Subjects With Advanced MTAP-null Solid Tumors

  • Protocol Number: 202112140
  • Principal Investigator: Morgensztern, Daniel
  • Cancer Types: Early Phase, Gastrointestinal, Head & Neck, Lung

For more information on this trial, contact us here:

[email protected]

Brief Summary

Protocol Interventions